
PDX模型
PDX模型(Patient-Derived tumor Xenograft model)为人源肿瘤异种移植瘤模型,主要通过将病人的新鲜肿瘤组织移植到免疫缺陷小鼠(如NCG)上构建而成。该模型能较完整地保持患者肿瘤原有的生物学特征、病理分型、分子标志物表达、基因突变类型等,保留了肿瘤的异质性、多样性和肿瘤微环境特征。集萃药康可提供多癌种PDX模型和基于PDX模型的药物筛选和药理药效分析服务。
胰腺癌PDX(Patient-Derived Xenograft)是一种用于研究和治疗胰腺癌的模型。它是通过将从患者体内获取的胰腺癌组织或细胞移植到小鼠等实验动物中形成的模型。胰腺癌PDX模型是一种重要的实验工具,可用于研究胰腺癌的发生机制、药物研发和个体化治疗策略的评估。
PDX ID | Histological type | Grade | Stage | WES | RNA-seq |
PC00125 | Adenocarcinoma | Low to medium differentiation | N/A | N/A | N/A |
PC00148 | Adenocarcinoma | N/A | N/A | Y | Y |
PC00169 | Ductal adenocarcinoma | Low to medium differentiation | N/A | N/A | Y |
PC00182 | Ductal adenocarcinoma | Low to medium differentiation | N/A | N/A | Y |
PC00183 | Ductal adenocarcinoma | Low to medium differentiation | N/A | N/A | N/A |
PC00184 | Ductal adenocarcinoma | Poorly differentiated | N/A | N/A | N/A |
PC00187 | Ductal adenocarcinoma | Moderate-severe differentiation | N/A | N/A | N/A |
PC00188 | Ductal adenocarcinoma | Low to medium differentiation | N/A | N/A | N/A |
PC00196 | Ductal adenocarcinoma | Low to medium differentiation | N/A | Y | Y |
PC00204 | Adenocarcinoma | Moderately differentiated | N/A | N/A | N/A |
PC00205 | Ductal adenocarcinoma | Moderately differentiated | N/A | N/A | Y |
PC00206-1 | Ductal adenocarcinoma | Moderately differentiated | N/A | Y | N/A |
PC00210 | Ductal adenocarcinoma | Moderately differentiated | N/A | N/A | Y |
PC00211 | Ductal adenocarcinoma | Low to medium differentiation | N/A | N/A | Y |
PC00212 | Ductal adenocarcinoma | Moderate-severe differentiation | N/A | N/A | Y |
PC00225 | Ductal adenocarcinoma | Moderately differentiated | N/A | N/A | Y |
PC00226 | Ductal adenocarcinoma | Low to medium differentiation | N/A | N/A | Y |
PC00231 | N/A | N/A | N/A | N/A | Y |
PC00236 | N/A | N/A | N/A | N/A | Y |
PC00237 | N/A | N/A | N/A | N/A | Y |
PC00250 | Ductal adenocarcinoma | Low to medium differentiation | N/A | N/A | Y |
PC00253 | N/A | N/A | N/A | N/A | Y |
PC00254 | N/A | N/A | N/A | N/A | N/A |
PC00258 | N/A | N/A | N/A | N/A | N/A |
PC00263 | N/A | N/A | N/A | N/A | Y |
PC00264 | Undifferentiated carcinoma of the pancreas | N/A | N/A | N/A | Y |
PC00266 | N/A | N/A | N/A | N/A | Y |
PC00279 | N/A | N/A | N/A | N/A | N/A |
PC00283 | N/A | N/A | N/A | N/A | Y |
PC00285 | N/A | N/A | N/A | Y | Y |
PC00287 | N/A | N/A | N/A | N/A | Y |
PC00290 | N/A | N/A | N/A | Y | Y |
PC00291 | N/A | N/A | N/A | N/A | Y |
PC00292 | N/A | N/A | N/A | N/A | Y |
PC00296 | N/A | N/A | N/A | N/A | Y |
PC00297 | N/A | N/A | N/A | N/A | Y |
PC00299 | Ductal adenocarcinoma | Moderately differentiated | N/A | N/A | Y |
PC00313 | Malignant gastrointestinal stromal tumor | N/A | N/A | N/A | Y |
PC00315 | N/A | N/A | N/A | N/A | Y |
PC00329 | N/A | N/A | N/A | N/A | Y |
PC00330 | Adenocarcinoma | Low to medium differentiation | N/A | N/A | Y |
PC00331 | Ductal adenocarcinoma | Low to medium differentiation | N/A | N/A | N/A |
PC00341 | N/A | N/A | N/A | N/A | Y |
PC00376 | N/A | N/A | N/A | N/A | Y |
PC00377 | N/A | N/A | N/A | N/A | Y |
PC00399 | N/A | N/A | N/A | N/A | N/A |
PC00410 | Ductal adenocarcinoma | Low to medium differentiation | N/A | N/A | Y |
PC00414 | N/A | N/A | N/A | N/A | Y |
PC00425 | Ductal adenocarcinoma | Moderate-severe differentiation | N/A | Y | Y |
PC00426 | Ductal adenocarcinoma | Low to medium differentiation | N/A | N/A | N/A |
PC00440 | N/A | N/A | N/A | N/A | Y |
PC00454 | N/A | N/A | N/A | N/A | Y |
PC00455 | N/A | N/A | N/A | N/A | Y |
PC00477 | N/A | N/A | N/A | N/A | N/A |
PC00481 | N/A | N/A | N/A | N/A | Y |
PC00484 | N/A | N/A | N/A | Y | Y |
PC00505 | N/A | N/A | N/A | N/A | Y |
PC00521 | N/A | N/A | N/A | N/A | N/A |
PC00526 | N/A | N/A | N/A | Y | Y |
PC00539 | Ductal adenocarcinoma | Moderately differentiated | N/A | N/A | N/A |
PC00541 | Ductal adenocarcinoma | Low to medium differentiation | N/A | N/A | Y |
PC00564 | N/A | N/A | N/A | N/A | Y |
PC00572 | N/A | N/A | N/A | N/A | Y |
PC00573 | N/A | N/A | N/A | N/A | N/A |
PC00601 | Adenocarcinoma | N/A | N/A | N/A | N/A |
PC00611 | Low-moderate differentiate adenocarcinoma | N/A | N/A | N/A | N/A |
PC00625 | N/A | N/A | T2N0M0 | N/A | N/A |
PC00627 | N/A | N/A | ⅡB(T3N1M0) | N/A | N/A |
PC00633 | Adenocarcinoma | N/A | N/A | N/A | N/A |
PC00696 | Moderately differentiated adenocarcinoma | N/A | N/A | N/A | N/A |